Loading edition detail...
Preparing this view.
Join BookitisSave favorites, build lists, and follow creators.
Preparing this view.
Steve Olson, Adam C. Berger
"Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research."
| Publisher | National Academies Press |
|---|---|
| Pages | 67 |
| Search language | english |
| ISBN_10 | 0-309-15954-7 primary |
| ISBN_13 | 978-0-309-15954-8 primary |
Publication-specific alternatives linked to the same work.
Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research
Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research
Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research
Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research